Kronox Lab Sciences Ltd
KRONOX NSE
Kronox Lab Sciences Ltd
ChemicalsNSE: KRONOX BSE: 544187 Specialty Chemicals
Key Fundamentals
MicrocapSpecialty ChemicalsChemicalsMarket Cap
₹606 Cr
Volatility
Moderate
P/E Ratio
22.01
EBITDA
₹34.27 Cr
Return on Equity
28.26%
Debt to Equity
0.02
Book Value
₹31.3
EPS
₹5.69
52W High
₹180.5
52W Low
₹96
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Kronox Lab Sciences Ltd insights
29 extracted metrics + investor summaries across FY20–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
4- Company is almost debt free.
- Company has delivered good profit growth of 23.3% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 31.4%
- Company's working capital requirements have reduced from 128 days to 71.2 days
Weaknesses
1- The company has delivered a poor sales growth of 10.1% over past five years.
Growth Rate
Revenue Growth
-1.44% ↘
Net Income Growth
8.16% ↘
Cash Flow Change
76.23% ↗
ROE
-12.24% ↘
ROCE
-11.85% ↘
EBITDA Margin (Avg.)
-7.20% ↘
Quarterly Results
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 21.47 | 25.95 | 21.02 | 20.71 | 22.18 | 25.19 | 24.86 | 24.01 | 26.13 | 24.29 | 25.53 | 25.27 | 26.13 |
| Expenses | 17.48 | 17.43 | 15.16 | 14.63 | 14.33 | 16.98 | 16.06 | 15.65 | 18.38 | 16.32 | 16.88 | 17.24 | 16.61 |
| Operating Profit | 3.99 | 8.52 | 5.86 | 6.08 | 7.85 | 8.21 | 8.8 | 8.36 | 7.75 | 7.97 | 8.65 | 8.03 | 9.52 |
| OPM % | 18.58% | 32.83% | 27.88% | 29.36% | 35.39% | 32.59% | 35.4% | 34.82% | 29.66% | 32.81% | 33.88% | 31.78% | 36.43% |
| Other Income | 0.14 | 0.24 | 0.49 | 0.02 | 0.83 | 0.43 | 0.36 | 0.82 | 0.91 | 0.87 | 1.04 | 1.13 | 2.15 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0.04 | 0.04 |
| Depreciation | 0.3 | 0.32 | 0.38 | 0.3 | 0.29 | 0.33 | 0.34 | 0.36 | 0.35 | 0.4 | 0.47 | 0.52 | 0.66 |
| PBT | 3.83 | 8.44 | 5.97 | 5.8 | 8.39 | 8.31 | 8.82 | 8.82 | 8.31 | 8.44 | 9.18 | 8.6 | 10.97 |
| Tax % | 36.55% | 24.53% | 27.14% | 18.28% | 29.92% | 25.99% | 26.64% | 26.08% | 24.07% | 25.71% | 27.23% | 23.37% | 26.98% |
| Net Profit | 2.44 | 6.38 | 4.35 | 4.74 | 5.88 | 6.15 | 6.47 | 6.53 | 6.32 | 6.28 | 6.68 | 6.59 | 8 |
| EPS in Rs | 0.66 | 1.72 | 1.17 | 1.28 | 1.58 | 1.66 | 1.74 | 1.76 | 1.7 | 1.69 | 1.8 | 1.78 | 2.16 |
Profit & Loss
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 50 | 62 | 82 | 96 | 90 | 100 | 101 |
| Expenses | 39 | 48 | 63 | 74 | 62 | 67 | 67 |
| Operating Profit | 12 | 15 | 20 | 22 | 28 | 33 | 34 |
| OPM % | 23% | 24% | 24% | 23% | 32% | 33% | 34% |
| Other Income | 1 | 1 | 1 | 2 | 2 | 3 | 5 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 2 | 2 | 2 | 1 | 1 | 2 |
| PBT | 12 | 13 | 18 | 22 | 29 | 34 | 37 |
| Tax % | 27% | 26% | 26% | 26% | 25% | 26% | 26% |
| Net Profit | 9 | 10 | 14 | 16 | 21 | 25 | 28 |
| EPS in Rs | 344 | 404 | 566 | 4.42 | 5.75 | 6.86 | 7.45 |
| Div. Payout % | 0% | 0% | 0% | 0% | 9% | 7% | 7% |
Balance Sheet
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.25 | 0.24 | 0.24 | 37 | 37 | 37 | 37 |
| Reserves | 23 | 27 | 40 | 8 | 29 | 53 | 79 |
| Borrowings | 0 | 4 | 3 | 0 | 0 | 0 | 2 |
| Other Liabilities | 11 | 7 | 13 | 9 | 8 | 9 | 10 |
| Total Liabilities | 34 | 38 | 57 | 54 | 74 | 99 | 128 |
| Fixed Assets | 6 | 9 | 11 | 16 | 26 | 28 | 29 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 29 | 28 | 45 | 38 | 47 | 70 | 98 |
| Total Assets | 34 | 38 | 57 | 54 | 74 | 99 | 128 |
Cash Flow
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Operating | 4 | 11 | 9 | 20 | 17 | 31 | 24 |
| Investing | -4 | -3 | -8 | -7 | -17 | -28 | -24 |
| Financing | 0 | -7 | -1 | -13 | 0 | -2 | 0 |
| Net Cash Flow | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
| Free Cash Flow | 3 | 10 | 5 | 11 | 5 | 28 | 21 |
| CFO/OP | 65 | 100 | 70 | 117 | 87 | 120 | 98 |
Ratios
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 110 | 90 | 114 | 71 | 72 | 72 | 76 |
| Inventory Days | 70 | 58 | 58 | 61 | 74 | 46 | 66 |
| Days Payable | 102 | 69 | 89 | 52 | 51 | 52 | 52 |
| Cash Conversion Cycle | 78 | 79 | 84 | 80 | 94 | 66 | 90 |
| Working Capital Days | 100 | 95 | 122 | 83 | 143 | 168 | 71 |
| ROCE % | — | 50% | 51% | 50% | 52% | 44% | 36% |
Documents
1
Clarification On Price Movement
8 Apr - Kronox Lab Sciences clarifies share price movement is market-driven and no undisclosed information exists. 8 Apr - Kronox Lab Sciences clarifies share price movement is market-driven and no undisclosed information exists.
2
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
3 Apr - Submitted Regulation 74(5) certificate for quarter ended 31 March 2026. 3 Apr - Submitted Regulation 74(5) certificate for quarter ended 31 March 2026.
3
Clarification sought from Kronox Lab Sciences Ltd
16 Jul - Exchange has sought clarification from Kronox Lab Sciences Ltd on July 16, 2026, with reference to Movement in Volume. 16 Jul - Exchange has sought clarification from Kronox Lab Sciences Ltd on July 16, 2026, with reference to Movement in Volume.
Frequently Asked Questions about Kronox Lab Sciences Ltd
What does Kronox Lab Sciences Ltd do?
Incorporated in 2008, Kronox Lab Sciences Ltd manufactures High Purity Fine, inorganic chemicals, phosphate, and metallic chemicals[1]
Where is Kronox Lab Sciences Ltd (KRONOX) listed?
Kronox Lab Sciences Ltd is listed on the Indian stock exchanges. It is listed on NSE: KRONOX and BSE: 544187. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Kronox Lab Sciences Ltd belong to?
Kronox Lab Sciences Ltd operates in the Chemicals sector within the Specialty Chemicals industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Kronox Lab Sciences Ltd?
Kronox Lab Sciences Ltd has a market capitalisation of approximately ₹606.21 Cr. Based on this, it is classified as a Small Cap stock.
What is the PE ratio of Kronox Lab Sciences Ltd?
The Price-to-Earnings (PE) ratio of Kronox Lab Sciences Ltd is 22.01. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Kronox Lab Sciences Ltd?
Over the past 52 weeks, Kronox Lab Sciences Ltd has traded between a low of ₹96 and a high of ₹180.5. This range helps investors understand the stock's price volatility and recent trading levels.
Does Kronox Lab Sciences Ltd pay dividends?
Yes, Kronox Lab Sciences Ltd has a dividend yield of 0.30%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of Kronox Lab Sciences Ltd?
Kronox Lab Sciences Ltd has a Return on Equity (ROE) of 28.26%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Kronox Lab Sciences Ltd on Tapetide?
On Tapetide, you can view Kronox Lab Sciences Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
Incorporated in 2008, Kronox Lab Sciences Ltd manufactures High Purity Fine, inorganic chemicals, phosphate, and metallic chemicals[1]